Of these, 16 IRF1-correlated pathways were associated with both ARDS risk and patient survival (Fig. 3B; Supplementary Table 4); notably, three of these pathways were related to SARS-CoV infection or therapy (Fig. 3B). This evidence concerns the gene IRF1 and severe acute respiratory syndrome.